The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
May 15th 2024
The continuation of tezepelumab showed stronger benefits after stopping treatment for 2 years and compared with placebo.